Global In Vitro Fertilization (IVF) Treatment Market Growth (Status and Outlook) 2025-2031

According to this study, the global In Vitro Fertilization (IVF) Treatment market size will reach US$ 1740 million by 2031.

In vitro fertilization (IVF) is a procedure designed to improve fertility in patients who have not been successful with ovulation induction or intrauterine insemination, or who are not candidates for those more conservative treatments. An egg (or several eggs) is surgically removed from the ovary and fertilized within a laboratory environment. The fertilized egg, now considered an embryo, is then implanted into the uterus.

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “In Vitro Fertilization (IVF) Treatment Industry Forecast” looks at past sales and reviews total world In Vitro Fertilization (IVF) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Fertilization (IVF) Treatment sales for 2025 through 2031. With In Vitro Fertilization (IVF) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Fertilization (IVF) Treatment industry.

This Insight Report provides a comprehensive analysis of the global In Vitro Fertilization (IVF) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Fertilization (IVF) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Fertilization (IVF) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Fertilization (IVF) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Fertilization (IVF) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Fertilization (IVF) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
VF-ET
ICSI
PGD

Segmentation by Application:
Fertility Clinics
Hospitals
Reaearch Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AMP Center St Roch
AVA Clinic
Bangkok IVF Center
Betamedics
Bloom Fertility Center
Bourn Hall
CHA Fertility Center
Chelsea and Westminster Hospital
Cloudnine Fertility
Cyprus IVF Centre
Dansk Fertilitetsklinik
FIV Marbella
Genea Oxford Fertility
Houston Fertility Center
IVI Panama
Lifesure Fertility and Gynaecology Centre
LIV Fertility Center
Manipal Fertility
OVA IVF
Procrea Fertility

Please note: The report will take approximately 2 business days to prepare and deliver. Show more